×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 3: Registries supporting Real World Evidence (RWE)
Session Chair(s)
Claudio Lavareda Santos
SVP Head of Global Medical Affairs
PTC Therapeutics Inc., United States
Session 3: Registries supporting Real World Evidence (RWE)
Speaker(s)
Global development plan – changes in CT on the horizon? Followed by: Real-world evidence to inform decision making of cell and gene therapies
Claudio Lavareda Santos
PTC Therapeutics Inc., United States
SVP Head of Global Medical Affairs
EMA Approach on Post-licensing Evidence Collection and Registries for Decisions Making
Nuria Semis-Costa, MSc
European Medicines Agency, Netherlands
Scientific Specialist (Risk Management)